STOCK TITAN

Long Path (MLAB) holds 8.6% of Mesa Laboratories, 477,126 shares

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Mesa Laboratories, Inc. amendment to a Schedule 13G/A reports that Long Path-affiliated entities collectively beneficially hold 477,126 shares of Common Stock, equal to 8.6% of the class. Percentage ownership is calculated from 5,524,931 shares outstanding as of May 21, 2026.

The filing names Long Path Smaller Companies Fund, Long Path Fund GP, Long Path Partners, Long Path Holdings LLC, William Thomas Brennan and Brian Paul Nelson as reporting persons and states the shares are directly held by the Fund with disclaimers of beneficial ownership by each reporting person except for pecuniary interest.

Positive

  • None.

Negative

  • None.

Insights

Long Path holds an 8.6% stake in Mesa Laboratories via its fund.

The Schedule 13G/A amendment lists 477,126 shares held by the Fund and affiliated entities, representing 8.6% of the issuer based on May 21, 2026 outstanding shares. The filing clarifies voting and dispositive power as shared and attributes ownership to the Fund.

Future disclosures in filings may show changes; this amendment is a positional disclosure rather than a transaction notice. Cash‑flow treatment or planned disposals are not described in the provided excerpt.

Shares held 477,126 shares reported beneficially held by the Fund and affiliates
Percent of class 8.6% percentage ownership based on outstanding shares
Shares outstanding 5,524,931 shares outstanding as of May 21, 2026 (used for percentage calculation)
CUSIP 59064R109 Mesa Laboratories Common Stock CUSIP
Schedule 13G/A regulatory
"This Amendment No. 2 to the Schedule 13G/A is filed by (i) Long Path Smaller Companies Fund"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
Beneficial ownership financial
"Amount beneficially owned: The information required by this paragraph is set forth in the cover pages"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared Dispositive Power financial
"Shared Dispositive Power 477,126.00"
Shared Voting Power financial
"Shared Voting Power 477,126.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Long Path report in Mesa Laboratories (MLAB)?

Long Path-affiliated entities report ownership of 477,126 shares, representing 8.6% of Mesa Laboratories' common stock. This percentage uses 5,524,931 shares outstanding as of May 21, 2026, per the issuer's Form 10-K cited in the filing.

Which Long Path entities are listed in the Schedule 13G/A amendment?

The amendment names Long Path Smaller Companies Fund, LP; Long Path Fund GP, LLC; Long Path Partners, LP; Long Path Holdings LLC, plus individuals William Thomas Brennan and Brian Paul Nelson as reporting persons, with the Fund holding the shares directly.

How is voting and dispositive power reported for these shares?

The filing shows 0 sole voting and dispositive power and 477,126 shares of shared voting and shared dispositive power, indicating the Fund and affiliated entities share control over voting and disposition of the reported shares.

What outstanding share count is used to calculate the 8.6% figure?

The percentage is based on 5,524,931 shares outstanding as of May 21, 2026, as reported in Mesa Laboratories' Form 10-K for the fiscal year ended March 31, 2026, which the amendment cites for its calculation.

Does the amendment state that any shares were bought or sold?

No. This Schedule 13G/A amendment reports beneficial ownership and attributes the position to the Fund; it does not disclose any purchase or sale transactions or changes in holdings within the provided excerpt.





59064R109

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Long Path Smaller Companies Fund, LP
Signature:/s/ William Thomas Brennan
Name/Title:William Thomas Brennan/Managing Member of Long Path Fund GP, LLC, its general partner
Date:07/07/2026
Long Path Fund GP, LLC
Signature:/s/ William Thomas Brennan
Name/Title:William Thomas Brennan/Managing Member
Date:07/07/2026
Long Path Partners, LP
Signature:/s/ William Thomas Brennan
Name/Title:William Thomas Brennan/Managing Member of Long Path Holdings LLC, its general partner
Date:07/07/2026
Long Path Holdings LLC
Signature:/s/ William Thomas Brennan
Name/Title:William Thomas Brennan/Managing Member
Date:07/07/2026
William Thomas Brennan
Signature:/s/ William Thomas Brennan
Name/Title:William Thomas Brennan/individually
Date:07/07/2026
Brian Paul Nelson
Signature:/s/ Brian Paul Nelson
Name/Title:Brian Paul Nelson/individually
Date:07/07/2026